Rubella virus infection poses a great threat to the foetus whose mother acquires the infection. This study was therefore carried out to determine the seroprevalence of rubella virus IgM antibodies among the pregnant women attending Federal Teaching Hopsital, Ido Ekiti. One hundred and ninety two (192) sera were collected from pregnant women and screened for rubella virus IgM antibodies. A structured questionnaire was administered to subjects to obtain socio-demographic data. The sera samples were analysed using Enzymes Immunosorbent Assay (EIA) IgM rubella kit. Out of 192 pregnant women screened, 6(3.1%) subjects were sero-positive. Age group 31-35years recorded the highest prevalence 3(1.56%). Pregnant women with tertiary education had the highest prevalence of 4(2.08%) among different educational level; civil servants have a prevalence of 4(2.08%) compared with other occupational status. However, prenatal screening and post-partum is highly encouraged to detect congenital rubella syndrome. There is also a need to include rubella screening as part of the routine procedure for the expectant mother.
Z.E. Jawetz, D.L. Melnick, E.A. Adelberg (2007). Paramyxoviruses and rubella virus. Brooks. G.F. Geo, F.B, Janet S.B, Stephen. In: Medical Microbiology, 22nd ed. (JavetzMelnick, Adelberg). A lange Medical book, pp 470-487.
J. Rahi, G. Adams, I. Russell –Eggitt, P. A. Tookey, M. Contiap –Borja and C.S. Pecklam (2000). Rubella Susceptibility among pregnant women in North London, 1996-1999. New England Journal of Medicine.234-240.
CDC (2004) Rubella vaccination.
B. J. Stegmann and J.C. Carey (2002). “Torch infection. Toxoplasmosis, other (syphilis, VC, Parvovirus B19), rubella, CMV and Herpes” Curr Women’s Health rep 2(4): 253-8.
R. F. Edlich, K.L. Winter, W. B. Long, K. D. Guber (2005) “Rubella and congenital rubella” J. Long Term Eff. Med Immplants 15(3):319-28.
J. C. Watson, S.C. Hadler, C.C. Dykewicz, S. Reefs, L. Philips, (1998). Measles, Mumps and Rubella-Vaccine use and strategies for elimination of Measles, Rubella, and congenital rubella syndrome and control of Mumps; Recommendations of the advisory committee on Immunization Practices (ACIPn). Recomm Rep 47(RR-8) :1-57.
B. Aishatu, S.O. S. Gubio, and A.M. Mukhtar. (2007) Seroprevalence of rubella virus among pregnant women in Kaduna State, Nigeria. Journal of Public Health informatics. 9(1): e185.
C.C. Onyenekwe, T.A. Kehinde, U. S. Ofor, O.G. Aribola, (2000). Prevalence of Rubella IgG antibody in women of child bearing age. West Africa J. Med. 19(1): 23-26.
C.O. Eleazu, E.K. Chnedum and A. Esther (2012). Survey of the seroprevalence of IgM antibodies in pregnant women infected with Rubella virus in Plateau State Specialist Hospital in Jos. Journal of biotechnology and Pharmaceutical research. 3(1)10-14.
B.J. Okonko, I.I. Cookies, I.O. Okonko, and O. Ogbu, (2020) Prevalence of Rubella IgG antibodies among pregnant women in River State, Nigeria. Journal of Advances in Medicine and Medical Research; 49-58.
J. M. Best, (2007). Rubella. Semin Feta neonatal med. 12(3): 182-92.
N. A. Taku, V.N. Ndze, J.P. Icenogle (2019). Seroprevalence of Rubella virus antibodies among pregnant women in the centre and south-west regions of Cameroon. PLos one. 14(11):e0225594.
F. T. Cutis, A. Abebe, and T. Messele (2000). Sero-epidemiology of rubella in the urban population o Addis Ababa. Epidemiology of infection. 124(3): 467-79.
J. U. Onakewhor and J. Chiwuzie (2011) Seroprevalence survey of Rubella infection in pregnancy at the Univesity of Benin Teaching Hospital, Benin City, Nigeria. Niger J. Clinical practice. 14(2):140-5.
R. Shaheen, D.K. Kakru, G.B. Kauser and SIN Hussain (2008). Sero –prevalence of Rubella Antibodies in the Kashmiri Pregnant women. Indian Journal for the Practising doctor. 5(2): 5-6.
This work is licensed under a Creative Commons Attribution 4.0 International License.